ACORN's Oncology-focused Contract Research Organization Exceeds Projections

Accelerated Community Oncology Research Network, Inc. Surpasses 2007 Outlook

MEMPHIS, Tenn., March 31 /PRNewswire/ -- The Accelerated Community
Oncology Research Network, Inc. (ACORN), a national oncology clinical trial
network, announced today that its Contract Research Organization (CRO)
exceeded performance expectations over the past 12 months. ACORN's CRO
provides the full range of research services to sponsors, from clinical trial
design to site selection to the results phase with bioanalysis and findings
presentation. "Sponsors have embraced the strength of ACORN CRO oncology
focus. We are pleased that our activity in 2007 exceeded our projections and
1st Q 2008 appears equally impressive," remarked Steve Coplon, CEO.
(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )
Exclusively focused on oncology, ACORN CRO is backed by scientists and
medical professionals dedicated to advancing cancer care through research. An
important added strength resides in ACORN's network of community oncology
researchers, specifically selected because of their commitment to oncology
research and excellence in its execution. Close working relationships with
demographically diverse US oncology practices result.
ACORN, Inc., a privately held company, significantly enhances the speed,
accuracy, and productivity of conducting clinical research in the community
oncology setting. Proactive project management with focused teams of clinical
experts achieves these goals. Well-defined processes augmented by proprietary
technology provide oversight and efficiencies on study functions for both
pharma and participating sites.
Strong site relationships enable ACORN CRO to achieve enrollment targets
within required timelines. Well-defined processes for site selection include
comprehensive study-specific questionnaires, feasibility assessments, and
expert evaluation of potential sites, ensuring a high probability of success
for each study.
ACORN CRO project teams collaborate with sponsors and stay in close
contact with investigator sites. Detailed communication, from kick-off
meetings to weekly teleconferences to tracking each study ensures that
sponsors are current with their study progress. Advanced technology enables
comprehensive metrics reports for in-depth study status.
For additional information visit www.ACORNresearch.net or contact Liz
Conway, Director of Marketing and Corporate Services, 901-259-0878.
Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN
focuses on oncology exclusively. ACORN offers centralized clinical trial
services, scientific analysis, and is a full-service Clinical Research
Organization (CRO), providing contract and budgeting services; fostering
accrual of subjects at the site level; collecting data and monitoring its
accuracy; and working seamlessly with both trial sponsors and participating
practices.
Contact Information:
Liz Conway
(901) 435-5570
lconway@sosacorn.com
www.ACORNresearch.net

Deborah D. Coble
901-683-0055x1312
dcoble@sosacorn.com

SOURCE Accelerated Community Oncology Research Network, Inc.

Liz Conway, +1-901-435-5570, lconway@sosacorn.com; or Deborah D. Coble,
+1-901-683-0055 x1312, dcoble@sosacorn.com, both for Accelerated Community
Oncology Research Network, Inc.